Back to Search
MARK MALKIN, MD, FRCPC, FAAN
MD, FRCPC, FAAN
Neurology Physician
NPI: 1851344584IndividualAccepts Medicare
Education
OTHER
Class of 1979
Research & Publications (17)
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors.
PMID 17053987·Invest New Drugs·2007
3-trial
Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.
PMID 16614943·J Neurooncol·2006
3-trial
Systemic high-dose intravenous methotrexate for central nervous system metastases.
PMID 16344918·J Neurooncol·2006
3-trial
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma.
PMID 15305414·Cancer·2004
8-other
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
PMID 15279717·Neuro Oncol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1250 E MARSHALL ST, INTERNAL MEDICINE
RICHMOND, VA 23298 - Phone
- (804) 828-7999
Quick Facts
- NPI
- 1851344584
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 17
Are you this provider?
Claim Your Profile